Today's Date: April 30, 2024
Marin Software Launches AI-powered Anomaly Detector to Unlock Growth in Performance Marketing Campaigns   •   Welltower Reports First Quarter 2024 Results   •   Athletes, Entrepreneurs and Investors Gather in Detroit During the Draft to Discuss Working Together to Build Community and Gene   •   WEF Special Meeting Concludes in Riyadh With World Leaders Calling for Clear, Irreversible Path to Peace and Prosperity as Top G   •   Coursera Reports First Quarter 2024 Financial Results   •   Matchbox Launches New Mercedes-Benz Die-Cast Car to Celebrate the Reveal of the All-New Electric G-Class   •   EY Announces Avelo Airlines Founder Andrew Levy as an Entrepreneur Of The Year® 2024 Gulf South Award Finalist   •   Joby Expands California Manufacturing Facility, Rolls Second Aircraft Off Production Line   •   Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship   •   Gecko Robotics and Al Masaood Energy Partner to Help ADNOC Gas Revolutionize Asset Operations and Maintenance with AI and Advanc   •   SHATTERPROOF AND ANTHEM BLUE CROSS FOUNDATION PARTNER TO REDUCE HEALTHCARE STIGMA AROUND A SUBSTANCE USE DISORDER IN CALIFORNIA   •   POTTS LAW FIRM: WEST TEXAS WOMAN FILES MULTI MILLION DOLLAR LAWSUIT AGAINST TRUCKING COMPANY   •   Rock Tech Lithium announces feedstock supply agreement with C&D Logistics (Qingdao) Co., Ltd., a supply chain enterprise und   •   Hyliion and Victory Execute Letter of Intent to Deploy up to 10 KARNO™ Generators to H2 Energy Group   •   Scientific leaders gather at global summit in Denmark to advance knowledge and solutions on health and sustainability   •   THE KIDS MENTAL HEALTH FOUNDATION HOSTS INAUGURAL "FAMILY DAY CELEBRATION" TO KICK OFF MENTAL HEALTH AWARENESS MONTH   •   WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment   •   MemorialCare Miller Children's & Women's Hospital Long Beach Named Official Children's Hospital of Angels Baseball & Log   •   IEI Announces Groundbreaking e-Paper Display Solution for Sustainable Communication   •   The Grant Sherpa and WorkForce Strategies International Announce a Revolutionary Solution to Address the Skills Gap Crisis
Bookmark and Share

A Genetic Connection to Kidney Disease

A Genetic Connection to Kidney Disease

PR Newswire

How APOL1-mediated kidney disease can impact you, your kidneys and your family

MISSION, Kan., April 17, 2024 /PRNewswire/ -- (Family Features) A genetic condition that can cause kidney failure, APOL1-mediated kidney disease (AMKD) represents a group of kidney diseases associated with mutations (changes or variants) in the apolipoprotein L1 (APOL1) genes.

Typically, the APOL1 genes – of which every person has two, one from each parent – create proteins that play a role in immunity. However, some people are born with mutations in one or both genes, and having mutations in both can increase the risk of developing kidney disease and even kidney failure.

In honor of National AMKD Awareness Day on April 30, consider this information from the experts at the American Kidney Fund to better understand the disease and become APOL1 aware.

Understanding Risk Factors

Research shows Black people with kidney disease are more likely to develop kidney failure than any other racial or ethnic group. The reasons for these health disparities include social determinants of health, a higher burden of diabetes and high blood pressure in the Black community, barriers to health care access and genetics.

The APOL1 gene mutations evolved over the past 3,000-10,000 years in people who lived in western and central Africa and are associated with increased protection from a parasite carried by the tse tse fly that causes African sleeping sickness. While protecting from one disease, the mutation – if inherited in both APOL1 genes – is more likely to lead to kidney disease in those of certain African descent, including people who identify as Black, African American, Afro-Caribbean or Latina or Latino.

In fact, an estimated 13% of Black Americans have two APOL1 gene mutations, according to the American Kidney Fund. While not everyone who has two APOL1 mutations will get kidney disease, there is a 1 in 5 chance they will go on to develop AMKD.

Identifying Symptoms

If you have kidney damage, symptoms may not occur until your kidneys are close to failing. As kidney damage worsens, one or more of these symptoms may occur:

  • Protein in urine
  • Swelling in legs or weight gain
  • Feeling weak or tired
  • High blood pressure

Should these symptoms occur and you have a family history of kidney disease, talk to a doctor about getting tested for kidney disease, as testing is the only way to determine kidney function. AMKD can cause damage to parts of the kidney that filter blood or, in some cases, cause cells in the kidneys to die, which can lead to damage and scarring that may eventually lead to kidney failure.

Getting a Diagnosis

The only way to know if you have APOL1 gene mutations is to do genetic testing via a blood or saliva sample. Genetic testing may be considered if you have kidney disease and don't know the cause or if you're considering donating a kidney. Testing may also be considered if a family member is a carrier for the mutation. If you have questions about genetic testing, discuss your options with a doctor or ask for a referral to a genetic counselor.

Taking Steps to Prevent Kidney Disease

There are currently no treatments available for AMKD. However, there are steps you can take to protect your kidneys and promote general health. Work with your doctor to create a plan to prevent or delay the progression of kidney disease, which may include:

  • Doctor visits to check how your kidneys are working through urine and blood tests
  • Checking for and managing diabetes and high blood pressure
  • A healthy eating plan, which may involve limiting things like sodium (salt)
  • Taking prescription medications as directed
  • Being active at least 30 minutes each day of the week
  • Quitting smoking or using tobacco

If you have the APOL1 gene mutations, you may be able to take part in clinical trials. Trials could provide an opportunity for researchers to develop and test safe treatments for AMKD. Also speak with family members about having genetic testing done if you have the mutation as they may also have it.

Learn more and find additional resources at kidneyfund.org/APOL1aware.

Michael French

mfrench@familyfeatures.com

1-888-824-3337

editors.familyfeatures.com

About Family Features Editorial Syndicate

A leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/a-genetic-connection-to-kidney-disease-302119742.html

SOURCE Family Features Editorial Syndicate



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News